Počet záznamů: 1  

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test

  1. 1.
    SYSNO ASEP0544580
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVZáznam nebyl označen do RIV
    Poddruh JOstatní články
    NázevFive Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
    Tvůrce(i) Šimánek, V. (CZ)
    Pecen, Ladislav (UIVT-O) RID, SAI, ORCID
    Krátká, Z. (CZ)
    Fürst, T. (CZ)
    Řezáčková, H. (CZ)
    Topolčan, O. (CZ)
    Fajfrlík, K. (CZ)
    Sedláček, D. (CZ)
    Šín, R. (CZ)
    Pazdiora, P. (CZ)
    Zelená, H. (CZ)
    Slouka, D. (CZ)
    Kučera, R. (CZ)
    Číslo článku593
    Zdroj.dok.Diagnostics. - : MDPI
    Roč. 11, č. 4 (2021)
    Poč.str.14 s.
    Jazyk dok.eng - angličtina
    Země vyd.CH - Švýcarsko
    Klíč. slovaSARS-CoV-2 ; antibody ; immunoassay ; nucleocapsid protein ; serological diagnostics ; spike protein ; virus neutralization test
    Způsob publikováníOpen access
    DOI10.3390/diagnostics11040593
    AnotaceThere is an ongoing debate as to whether SARS-CoV-2 antibodies can be found in patients who have recovered from COVID-19 disease. Currently, there is no consensus on whether the antibodies, if present, are protective. Our regular measurements of SARS-CoV-2 antibodies, starting in July 2020, have provided us with the opportunity of becoming acquainted with the five different immunoassays. A total of 149 patients were enrolled in our study. We measured the samples using each immunoassay, then performing a virus neutralization test and comparing the results of SARS-CoV-2 antibodies with this test. We observed that the production of neutralizing antibodies is age-dependent. Elderly patients have a higher proportion of high neutralizing titers than young patients. Based on our results, and in combination with the literature findings, we can conclude that the serological SARS-CoV-2 antibody measurement is a helpful tool in the fight against COVID-19. The assays can provide information about the patient's previous contact with the virus. Anti-spike protein assays correlate well with the virus neutralization test and can be used in the screening of potential convalescent plasma donors.
    PracovištěÚstav informatiky
    KontaktTereza Šírová, sirova@cs.cas.cz, Tel.: 266 053 800
    Rok sběru2022
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.